Efficacy and Safety of Switching from Sitagliptin to Ipragliflozin in Obese Japanese Patients with Type 2 Diabetes Mellitus: A Single-Arm Multicenter Interventional Study

Watanabe, K; Yamaguchi, S; Kosakai, Y; Ioji, T; Ishihara, H

Watanabe, K (通讯作者),Nihon Univ, Dept Internal Med, Div Diabet & Metab Dis, Sch Med, 30-1 Oyaguchi Kamicho,Itabashi Ku, Tokyo 1738610, Japan.

CLINICAL DRUG INVESTIGATION, 2023; ():

Abstract

Background Dipeptidyl peptidase-4 inhibitors have limited efficacy in improving glycemic control for obese Japanese patients with type 2 diabetes mell......

Full Text Link